BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 10581328)

  • 21. Dendrimers as carriers for delivery of chemotherapeutic agents.
    Medina SH; El-Sayed ME
    Chem Rev; 2009 Jul; 109(7):3141-57. PubMed ID: 19534493
    [No Abstract]   [Full Text] [Related]  

  • 22. Liposomes for drug targeting in cancer chemotherapy.
    Liliemark J
    Eur J Surg Suppl; 1991 May; (561):49-52. PubMed ID: 1720049
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo enhancement of the experimental oncostatic effect of RFCNU by its encapsulation in liposomes.
    Mathé G; Bothorel P
    Biomedicine; 1981 Dec; 35(7-8):201-2. PubMed ID: 7346064
    [No Abstract]   [Full Text] [Related]  

  • 24. Liposomes as drug carriers in cancer therapy: hyperthermia and pH sensitivity as modalities for targeting.
    Yatvin MB; Cree TC; Tegmo-Larsson IM; Gipp JJ
    Strahlentherapie; 1984 Dec; 160(12):732-40. PubMed ID: 6393456
    [No Abstract]   [Full Text] [Related]  

  • 25. Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment.
    Salkho NM; Turki RZ; Guessoum O; Martins AM; Vitor RF; Husseini GA
    Curr Mol Med; 2017; 17(10):668-688. PubMed ID: 29663885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour-selective drug delivery via folate receptor-targeted liposomes.
    Pan X; Lee RJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):7-17. PubMed ID: 16296717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomes. Opportunities in drug delivery.
    Allen TM
    Drugs; 1997; 54 Suppl 4():8-14. PubMed ID: 9361956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional cancer treatment with magnetic drug targeting.
    Alexiou C; Arnold W; Klein RJ; Parak FG; Hulin P; Bergemann C; Erhardt W; Wagenpfeil S; Lübbe AS
    Cancer Res; 2000 Dec; 60(23):6641-8. PubMed ID: 11118047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.
    Takakura Y; Hashida M
    Crit Rev Oncol Hematol; 1995 Mar; 18(3):207-31. PubMed ID: 7695833
    [No Abstract]   [Full Text] [Related]  

  • 30. [Polyplex nanomicelles for drug delivery system].
    Itaka K
    Rinsho Ketsueki; 2008 May; 49(5):287-93. PubMed ID: 18572804
    [No Abstract]   [Full Text] [Related]  

  • 31. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome.
    Suzuki R; Takizawa T; Kuwata Y; Mutoh M; Ishiguro N; Utoguchi N; Shinohara A; Eriguchi M; Yanagie H; Maruyama K
    Int J Pharm; 2008 Jan; 346(1-2):143-50. PubMed ID: 17640835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microdialysis: an in vivo approach for measuring drug delivery in oncology.
    Brunner M; Müller M
    Eur J Clin Pharmacol; 2002 Jul; 58(4):227-34. PubMed ID: 12136367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Calcium antagonist as biological modulator in cancer chemotherapy].
    Tsuruo T
    Nihon Rinsho; 1989 Aug; 47(8):1851-6. PubMed ID: 2573744
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental affinity chemotherapy in cancer].
    Chen GJ; Wang SZ
    Sheng Li Ke Xue Jin Zhan; 1986 Apr; 17(2):154-9. PubMed ID: 2431479
    [No Abstract]   [Full Text] [Related]  

  • 35. [Controlled administration of antineoplastic drugs].
    Oborotova NA
    Antibiot Khimioter; 1991 Oct; 36(10):47-50. PubMed ID: 1805698
    [No Abstract]   [Full Text] [Related]  

  • 36. [Enhancement of antitumor effect of chemotherapeutic agents viewed from tumor-host relationship].
    Saito T
    Saishin Igaku; 1970 May; 25(5):1080-8. PubMed ID: 4912178
    [No Abstract]   [Full Text] [Related]  

  • 37. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents.
    Oku N; Namba Y
    Methods Enzymol; 2005; 391():145-62. PubMed ID: 15721379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomally targeted cytotoxic drugs for the treatment of cancer.
    Harrington KJ; Syrigos KN; Vile RG
    J Pharm Pharmacol; 2002 Dec; 54(12):1573-600. PubMed ID: 12542887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian cancer pharmacodynamics.
    Hrushesky WJ
    Ann Ist Super Sanita; 1993; 29(4):705-10. PubMed ID: 7985931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.